S. Korea, Sweden partner up to find Alzheimer's vaccine

South Korea and Sweden will team up to search for an Alzheimer's vaccine and develop products for senior citizens. The partnership will involve an active exchange between Sweden's group of brain research professionals, dubbed Brain Power, and South Korean researchers, The Korea Times reports. Sweden will take the lead because Stockholm's Karolinska Institutet has already begun research on a vaccine for Alzheimer's. Story

Suggested Articles

Merck has a big target in mind for its pneumococcal vaccine V114: Prevnar 13, the world's best-selling shot—and its phase 3 program shows it.

A Lancet Infectious Diseases study shows antibody response persists for two years or more after a single shot of Merck’s rVSV-ZEBOV vaccine.

Behind the under-pressure blockbuster Prevnar 13 are several pipeline vaccines Pfizer hopes will propel future growth.